Self-directed de-escalation of maintenance inhaler therapy in patients with severe asthma in remission with biologic treatment: An observational study
{{output}}
Background: mAbs targeting type 2 inflammation have significantly improved disease control in severe asthma. As more patients achieve clinical stability, the safety and outcomes of maintenance inhaled therapy (MIT) de-escalation ... ...
